• Home
  • News
    • Saturday, Dec. 9
    • Friday, Dec. 8
    • Thursday, Dec. 7
    • Wednesday, Dec. 6
    • Tuesday, Dec. 5
    • Monday, Dec. 4
    • 2023 Pre-Meeting
      • Nov. 20
      • Nov. 7
      • Oct. 17
      • Oct. 3
      • Sept. 19
      • Sept. 7
    • Archive
      • 2023
      • 2022
      • 2021
      • 2020
  • Attendee Map & Photos
  • Special Editions
  • Industry Events
    • Product Theaters
    • Satellite Educational Symposia
  • Featured Exhibitors
Meeting Home
Get News Updates
  • Home
  • News
    • Saturday, Dec. 9
    • Friday, Dec. 8
    • Thursday, Dec. 7
    • Wednesday, Dec. 6
    • Tuesday, Dec. 5
    • Monday, Dec. 4
    • 2023 Pre-Meeting
      • Nov. 20
      • Nov. 7
      • Oct. 17
      • Oct. 3
      • Sept. 19
      • Sept. 7
    • Archive
      • 2022
      • 2021
      • 2020
      • 2023
  • Attendee Map & Photos
  • Special Editions
  • Industry Events
    • Product Theaters
    • Satellite Educational Symposia
  • Featured Exhibitors
  • Get News Updates
  • Results from EMERALD trial and key findings from PI3K pathway inhibitor study presented at #SABCS21

    December 9, 2021

    Results from EMERALD trial and key findings from PI3K pathway inhibitor study presented at #SABCS21

    Wednesday’s General Session featured new data about the oral SERD elacestrant and the effect of tamoxifen on uterine cancer risk.

  • McGuire Award Lecture: Moving to precision care in breast cancer

    December 9, 2021

    McGuire Award Lecture: Moving to precision care in breast cancer

    Olufunmilayo I. Olopade, MD, FAACR, recounted her lifelong journey through breast cancer genomics during the William L. McGuire Memorial Lecture on Wednesday.

  • Regulatory session covers latest breast cancer treatment approvals

    December 9, 2021

    Regulatory session covers latest breast cancer treatment approvals

    A special session on Wednesday reviewed the Food and Drug Administration’s recent approval of pembrolizumab for neoadjuvant and adjuvant treatment, and abemaciclib in the adjuvant setting.

  • Twitter
  • Facebook
  • Instagram

© 2023 SABCS. All Rights Reserved. Powered By TriStar Event Media, LLC.

Privacy Policy

Get email updates from SABCSMeetingNews.org

Subscribe to get regular news updates from SABCS.org and SABCS Meeting News.